Syndicate content The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
Updated: 55 min 59 sec ago

Zimmer Announces Executive Leadership Team and New Name of Combined Company Following Closing

Thu, 10/30/2014 - 15:25
Combined Entity to be Named Zimmer Biomet WARSAW, Ind., Oct. 30, 2014 -- (Healthcare Sales & Marketing Network) -- Zimmer Holdings, Inc. (NYSE: ZMH and SIX: ZMH) today announced the future executive leadership team and organizational structure of the c...
Devices, Orthopaedic, Personnel, Mergers & Acquisitions
Zimmer, Biomet

U.S. FDA Approves Once-Daily XIGDUO(TM) XR Tablets for Adults with Type 2 Diabetes

Thu, 10/30/2014 - 15:20
First U.S. approval for once-daily tablet combining SGLT2 inhibitor and metformin HCl extended-release WILMINGTON, Del.--(Healthcare Sales & Marketing Network)--AstraZeneca (AZN) today announced that the U.S. Food and Drug Administration has approved on...
Biopharmaceuticals, Endocrinology, FDA
AstraZeneca, XIGDUO XR, dapagliflozin, metformin, diabetes

Omidria(TM) Granted Pass-Through Reimbursement Status from CMS

Thu, 10/30/2014 - 15:12
Unique Billing Code Allows Separate Payment for Omidria SEATTLE, Oct. 30, 2014 -- (Healthcare Sales & Marketing Network) -- Omeros Corporation (OMER) announced today that it has received transitional pass-through status for its lead product Omidria™ (p...
Biopharmaceuticals, Ophthalmology, Reimbursement
Omeros Corp, Omidria, phenylephrine, ketorolac, cataract surgery

Aileron Therapeutics Expands Senior Management Team

Wed, 10/29/2014 - 13:09
Company Appoints Manuel C. Aivado, M.D., Ph.D., as Chief Medical Officer and Donna M. Jarlenski as Vice President of Clinical Operations CAMBRIDGE, Mass.--(Healthcare Sales & Marketing Network)--Aileron Therapeutics, Inc., a clinical stage biopharmaceut...
Biopharmaceuticals, Oncology, Personnel
Aileron Therapeutics

Aileron Therapeutics Secures $33 Million in Series E Financing to Advance Its First-In-Class Cancer Drug

Wed, 10/29/2014 - 13:03
CAMBRIDGE, Mass.--(Healthcare Sales & Marketing Network)--Aileron Therapeutics, Inc., a clinical stage biopharmaceutical company that is developing first-in-class therapeutics based on its proprietary Stapled Peptide drug platform, announced today that it ...
Biopharmaceuticals, Oncology, Venture Capital
Aileron Therapeutics

Hanson Medical Systems Becomes Preferred Distributor for PTS Diagnostics' CardioChek Family of Products

Tue, 10/28/2014 - 14:01
INDIANAPOLIS, Oct. 28, 2014 -- (Healthcare Sales & Marketing Network) -- PTS Diagnostics, the U.S.-based manufacturer of both the CardioChek® brand and the A1CNow® family of point-of-care diagnostic products, has entered into a Preferred Distribut...
Diagnostics, Distribution
PTS Diagnostics, Hanson Medical Systems, CardioChek, A1CNow

Dallen Medical Receives FDA Clearance for Tensyn(TM) Band for AC/CC Joint Stabilization

Tue, 10/28/2014 - 13:54
SAN CLEMENTE, Calif.--(Healthcare Sales & Marketing Network)--Dallen Medical Inc., an innovator in bone fixation and repair, today announced 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Tensyn™ Band for acromioclavicular (AC) j...
Devices, Orthopaedic, FDA
Dallen Medical, Tensyn Band, syndesmosis repair

RaySearch Laboratories: Raysearch Receives FDA Clearance for RayStation 4.5 Featuring Ultrafast and Robust Optimization

Tue, 10/28/2014 - 13:45
STOCKHOLM--(Healthcare Sales & Marketing Network)--RaySearch Laboratories AB (publ) (STO:RAYB) has received 510(k) clearance from the FDA for version 4.5 of its treatment planning system RayStation®. The new version includes a wide range of new feat...
Devices, Oncology, FDA
RaySearch Laboratories, RayStation, treatment planning system, rayAutoBreast

Advent Life Sciences Raises £145.5M (USD 235M) for its Second Life Sciences Venture Capital Fund

Tue, 10/28/2014 - 13:36
LONDON, October 28, 2014 -- (Healthcare Sales & Marketing Network) -- Advent Life Sciences today announced the closing of Advent Life Sciences Fund II (ALSF II), a £145.5M (USD 235M) venture capital fund raised to seed and build life sciences compan...
Venture Capital
Advent Life Sciences

First Ever Five-Millimeter Laparoscopic Stapled Small Bowel Anastomosis Performed With Cardica's MicroCutter XCHANGE(R) 30

Mon, 10/27/2014 - 16:08
Performed on Emergency Basis Completed Laparoscopically with Three Five-Millimeter Trocars REDWOOD CITY, Calif., Oct. 27, 2014 -- (Healthcare Sales & Marketing Network) -- Juan-Carlos Verdeja, M.D., a leading surgeon, performed the first ever virtua...
Devices, Surgery
Cardica, MicroCutter XCHANGE, surgical staple

Covidien Launches Next-Generation SuperDimension(TM) Lung Navigation Software to Simplify Planning, Enhance Visualization During a Procedure

Mon, 10/27/2014 - 16:03
Company Delivers Latest Innovation Focused on Aiding in Diagnosis of Lung Cancer DUBLIN--(Healthcare Sales & Marketing Network)--Further underscoring its ongoing commitment to lung health, Covidien (COV) today unveiled a next-generation version of its s...
Devices, Oncology, Product Launch
Covidien, SuperDimension, bronchoscopy, Lung Navigation

Syros Pharmaceuticals Closes $53 Million Series B Financing

Mon, 10/27/2014 - 16:00
Includes Leading Public and Healthcare-Focused Funds Proceeds Will Accelerate Gene Control Programs and Platform WATERTOWN, Mass.--(Healthcare Sales & Marketing Network)--Syros Pharmaceuticals, a therapeutics company focused on discovering and develo...
Biopharmaceuticals, Venture Capital
Syros Pharmaceuticals

St. Jude Medical Receives FDA Approval of TactiCath Quartz Contact Force Ablation Catheter for Treatment of Atrial Fibrillation

Mon, 10/27/2014 - 15:52
TactiCath ablation catheter with contact-force measurement provides physicians with a new option for treating patients with atrial fibrillation ST. PAUL, Minn.--(Healthcare Sales & Marketing Network)--St. Jude Medical, Inc. (STJ), a global medical devi...
Devices, Cardiology, FDA
St. Jude Medical, TactiCath, ablation catheter, atrial fibrillation

Zogenix Acquires U.K.-Based Brabant Pharma

Mon, 10/27/2014 - 15:47
Obtains global rights for treatment option in development for Dravet syndrome, a rare and catastrophic form of epilepsy that begins in infancy Plans to initiate Phase 3 clinical studies of Brabafen(TM) in second quarter of 2015 Conference call and we...
Biopharmaceuticals, Neurology, Mergers & Acquisitions
Zogenix, Brabant Pharma, Brabafen, fenfluramine, Dravet syndrome

Aeterna Zentaris Announces Formal Implementation of its Sales Force In Support of Selling ASCEND's EstroGel(R)

Mon, 10/27/2014 - 15:43
QUÉBEC CITY, Oct. 27, 2014 -- (Healthcare Sales & Marketing Network) - Aeterna Zentaris Inc. (AEZS) (TSX: AEZ) (the "Company") today announced the formal implementation of its own full-time U.S. sales force with field selling of ASCEND Th...
Biopharmaceuticals, Distribution
Aeterna Zentaris, ASCEND Therapeutics, EstroGel

Myriad Establishes Tumor BRACAnalysis CDx(TM) Laboratory in Europe

Fri, 10/24/2014 - 13:15
Tumor BRACAnalysis CDx Will Identify More Patients for Treatment With PARP Inhibitors SALT LAKE CITY and ZURICH, Oct. 24, 2014 -- (Healthcare Sales & Marketing Network) -- Myriad Genetics, Inc. (MYGN) today announced it has established a Tumor BRACAnaly...
Diagnostics, Oncology
Myriad Genetics, BRACAnalysis CDx, PARP inhibitors

Elite Pharmaceuticals Announces New Management Appointments

Fri, 10/24/2014 - 13:07
NORTHVALE, N.J., Oct. 24, 2014 -- (Healthcare Sales & Marketing Network) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (ELTP),a specialty pharmaceutical company developing a pipeline of abuse-deterrent opioids and niche gene...
Biopharmaceuticals, Personnel
Elite Pharmaceuticals

Zyno Medical, LLC Receives FDA 510(k) Clearance for Ambulatory Infusion Pump

Fri, 10/24/2014 - 13:04
A Simple, Safe, and Reliable Ambulatory Infusion System NATICK, Mass., Oct. 24, 2014 -- (Healthcare Sales & Marketing Network) -- Zyno Medical, LLC today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) i...
Devices, FDA
Zyno Medical, Nimbus, ambulatory infusion system

QLT Appoints Dr. Geoffrey F. Cox as Interim Chief Executive Officer

Fri, 10/24/2014 - 13:00
Announces 2014 Annual General Meeting Date VANCOUVER, British Columbia, Oct. 24, 2014 -- (Healthcare Sales & Marketing Network) -- QLT Inc. (QLTI) (QLT.TO) ("QLT" or the "Company") today announced that current QLT Board member, Geoff...
Biopharmaceuticals, Ophthalmology, Personnel
QLT

The TransMedics(R) Organ Care System (OCS(TM)) Heart Technology Was Used to Perform The World's First Series of Adult Human Heart Transplants From Donors After Circulatory Death (DCD Donors) at St Vincent's Hospital in Sydney, Australia

Fri, 10/24/2014 - 12:53
ANDOVER, Mass. , Oct. 24, 2014 (Healthcare Sales & Marketing Network) -- TransMedics announces that its OCS ™ Heart technology was used to preserve and assess the world's first series of three successful adult heart transplant procedures from hearts donate...
Devices, Cardiology
TransMedics, Organ Care System, OCS Heart, transplantation

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong